The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BNTX FINANCIAL STATEMENTS

BioNTech SE — balance sheet, income statement and cash flow trends

BNTXBioNTech SE

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
010 B20 B202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue2.8 B €Gross Profit2 B € · 73%Operating Income-1.5 B € · -52%Pre-tax Income-1.2 B € · -42%Net Income-1.3 B € · -45%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.8 B €+1.9%
Gross Profit2 B €-6.1%
Operating Income-1.5 B €—
EBITDA-704.7 M €—
Net Income-1.3 B €—

Peer Comparison· Biotechnology

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
BNTX1.9%73.2%-25.2%-45.0%
Industry median4.1%84.0%-105.8%-125.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
010 B20 B202120222023202420252026

Capital Structure

Q1 2026
Total Assets21.1 B
  • Equity18.7 B €89%
  • Current Liabilities1.8 B €8%
  • Long-term Liabilities611.9 M €3%

Key Figures

YoY change
Total Assets21.1 B €-0.4%
Total Liabilities2.4 B €+5.5%
Total Equity18.7 B €-1.1%
Cash & ST Investments14.7 B €+3.8%
Total Debt303.1 M €+3.5%
Net Debt-9.6 B €—

Peer Comparison· Biotechnology

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
BNTX8.801.6%20.3688.7%
Industry median5.9010.9%1.1570.0%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
0500 M858 M €Operating-955.1 M €Investing-16.1 M €Financing-113.2 M €Net Change

Key Figures

YoY change
Operating Cash Flow858 M €—
Capital Expenditures730.6 M €-26.5%
Free Cash Flow1.3 B €—
Dividends Paid——

Peer Comparison· Biotechnology

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
BNTX30.7%45.1%26.1%-68.2%
Industry median-88.0%-90.9%1.9%81.5%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BNTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.